Search research articles
Contact Us
Filters
Showing results (51-60 of 206) with videos related to
Page
of 21
Sort By:
Medical Care
|
February 12, 2022
The Prescription Drug User Fee Act: Much More Than User Fees
Aaron P Mitchell, Niti U Trivedi, Peter B Bach
JAMA Oncology
|
December 26, 2025
Oncology Drug Revenue and Price Negotiation
Aaron P Mitchell, Rachel E Sachs, Stacie B Dusetzina
Journal of the National Cancer Institute
|
August 26, 2025
Industry promotion of oncology drugs with accelerated approval that failed confirmatory trials
Maryam Mooghali, Reshma Ramachandran, Ayman Mohammad, et al.
Trials
|
March 26, 2014
Lack of timely accrual information in oncology clinical trials: a cross-sectional analysis
Aaron P Mitchell, Bradford R Hirsch, Amy P Abernethy
Current Protocols
|
March 9, 2023
Correction: Targeted Genetic Changes in Candida albicans Using Transient CRISPR-Cas9 Expression
Manning Y Huang, Max V Cravener, Aaron P Mitchell
Current Protocols
|
January 25, 2021
Targeted Genetic Changes in Candida albicans Using Transient CRISPR-Cas9 Expression
Manning Y Huang, Max C Cravener, Aaron P Mitchell
Msphere
|
April 27, 2018
Rapid Gene Concatenation for Genetic Rescue of Multigene Mutants in <i>Candida albicans</i>
Manning Y Huang, Carol A Woolford, Aaron P Mitchell
JAMA Internal Medicine
|
April 10, 2018
Pharmaceutical Industry Payments and Oncologists' Selection of Targeted Cancer Therapies in Medicare Beneficiaries
Aaron P Mitchell, Aaron N Winn, Stacie B Dusetzina
JAMA Oncology
|
August 26, 2016
Financial Relationships With Industry Among National Comprehensive Cancer Network Guideline Authors
Aaron P Mitchell, Ethan M Basch, Stacie B Dusetzina
Cold Spring Harbor Perspectives in Medicine
|
October 3, 2014
Fungal biofilms, drug resistance, and recurrent infection
Jigar V Desai, Aaron P Mitchell, David R Andes
Page
of 21
Search research articles
Search
Showing results (51-60 of 206) with videos related to
Sort By:
Page
of 21
Medical Care
|
February 12, 2022
The Prescription Drug User Fee Act: Much More Than User Fees
Aaron P Mitchell, Niti U Trivedi, Peter B Bach
JAMA Oncology
|
December 26, 2025
Oncology Drug Revenue and Price Negotiation
Aaron P Mitchell, Rachel E Sachs, Stacie B Dusetzina
Journal of the National Cancer Institute
|
August 26, 2025
Industry promotion of oncology drugs with accelerated approval that failed confirmatory trials
Maryam Mooghali, Reshma Ramachandran, Ayman Mohammad, et al.
Trials
|
March 26, 2014
Lack of timely accrual information in oncology clinical trials: a cross-sectional analysis
Aaron P Mitchell, Bradford R Hirsch, Amy P Abernethy
Current Protocols
|
March 9, 2023
Correction: Targeted Genetic Changes in Candida albicans Using Transient CRISPR-Cas9 Expression
Manning Y Huang, Max V Cravener, Aaron P Mitchell
Current Protocols
|
January 25, 2021
Targeted Genetic Changes in Candida albicans Using Transient CRISPR-Cas9 Expression
Manning Y Huang, Max C Cravener, Aaron P Mitchell
Msphere
|
April 27, 2018
Rapid Gene Concatenation for Genetic Rescue of Multigene Mutants in <i>Candida albicans</i>
Manning Y Huang, Carol A Woolford, Aaron P Mitchell
JAMA Internal Medicine
|
April 10, 2018
Pharmaceutical Industry Payments and Oncologists' Selection of Targeted Cancer Therapies in Medicare Beneficiaries
Aaron P Mitchell, Aaron N Winn, Stacie B Dusetzina
JAMA Oncology
|
August 26, 2016
Financial Relationships With Industry Among National Comprehensive Cancer Network Guideline Authors
Aaron P Mitchell, Ethan M Basch, Stacie B Dusetzina
Cold Spring Harbor Perspectives in Medicine
|
October 3, 2014
Fungal biofilms, drug resistance, and recurrent infection
Jigar V Desai, Aaron P Mitchell, David R Andes
Page
of 21